Insider Trading & Executive Data
Start Free Trial
18 insider trades in the last year. Go beyond summary counts with transaction-level detail, compensation intelligence, and institutional ownership context.
CareTrust REIT is a self‑administered healthcare REIT that acquires, finances, develops and leases skilled nursing facilities, multi‑service campuses, assisted living and independent living properties. As of year‑end 2024 it directly owned or leased 258 properties (28,088 beds/units) and controlled 437 facilities (45,985 beds/units) with a portfolio carrying value of ~$3.175 billion; rental income (~83% of 2024 revenue) and interest on mortgage/mezzanine investments are the primary cash generators. Growth to date has been acquisition‑ and lending‑driven (large 2024 and 2025 deal activity including the Care REIT plc acquisition), funded heavily via equity issuances (ATM/follow‑ons), joint ventures and debt, while the company monitors tenant EBITDAR/EBITDARM, occupancy and collections closely. Key operating risks are tenant concentration (Ensign ≈28% of contractual rent), geographic concentration (California, Texas), regulatory healthcare rules (CMS staffing, False Claims/Anti‑Kickback) and macro pressures (labor, inflation, interest rates).
Compensation is likely oriented toward metrics that reflect REIT cash generation and portfolio health: rental income growth, FFO/AFFO or similar cash‑flow measures (to support dividends), rent/interest collection rates and successful accretive acquisitions and loan originations. Management already recognizes meaningful incentive and share‑based pay (G&A rose in H1 2025 driven by incentive and equity compensation), so a material portion of pay is tied to equity‑linked awards — aligning executives with stock performance but also creating dilution pressure given the company’s frequent ATM and follow‑on issuances. Because CareTrust is self‑administered with a small employee base and centralized decision authority, compensation structures may include deal‑specific overrides or performance gates (e.g., acquisition funding, JV preferred returns, loan performance) to reward growth while preserving dividend coverage. Regulatory and tenant‑performance risks (CMS changes, state wage laws, impaired tenants) mean compensation plans may include downside protections or clawbacks tied to impairment charges, loan losses or covenant breaches.
Insider trading activity should be viewed in the context of frequent equity issuance and large acquisitions: insiders may sell following equity raises (ATMs/follow‑ons) to monetize equity awards, and purchases may cluster after sharp price drops or ahead of announced accretive deals. Watch for option exercises, scheduled 10b5‑1 plans and blocker sales tied to share‑based compensation vesting; the company explicitly disclosed higher share‑based incentive expense in 2025. Material catalysts that could drive insider timing include acquisition closings (Care REIT plc), debt financings/hedging actions, tenant credit deterioration or CMS/regulatory updates that affect operator economics and occupancy. Given concentrated tenant exposure and a small executive team, even modest insider buys or sells can signal management views on dividend sustainability, leverage tolerance and the risk profile of the portfolio.